Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07446582
What this trial is testing

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

Who this might be right for
Age-Related (Dry) Macular Degeneration
AI-Spectral 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Testing effectiveness (Phase 2)Study completedNCT02684578
What this trial is testing

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration, Age-RelatedDry Macular Degeneration+1 more
University of California, San Francisco 66
Not applicableUnknownNCT05763940
What this trial is testing

Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

Who this might be right for
Dry Eye SyndromesAge-Related Macular DegenerationOmega 3 Index
Western University of Health Sciences 130
Not applicableActive Not RecruitingNCT05797896
What this trial is testing

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyRetinal Disease+4 more
Complement Therapeutics 250
Large-scale testing (Phase 3)Looking for participantsNCT06165068
What this trial is testing

Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study

Who this might be right for
Dry Age-related Macular Degeneration
Navamindradhiraj University 174
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Not applicableUnknownNCT04268836
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Optimal Acuity Corporation 200
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT02463344
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 11
Not applicableEnded earlyNCT01337414
What this trial is testing

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Johns Hopkins University 324
Not applicableLooking for participantsNCT07255859
What this trial is testing

AVIGA3 (Cohort 2.0)

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Not applicableUnknownNCT03859245
What this trial is testing

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Who this might be right for
Diabetic Retinopathy (DR)Age-related Macular Degeneration (AMD)Mid-peripheral Drusen Formation+1 more
Bristlecone Health, Inc. 30
Not applicableLooking for participantsNCT06536062
What this trial is testing

Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Next Page